No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1ao6B1, 1.0000, 0.00, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
2, d1bm0B1, 0.9980, 0.23, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
3, d1ao6A1, 0.9972, 0.27, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
4, d1bm0A1, 0.9960, 0.32, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
5, d3lu7B1, 0.9940, 0.40, 1.000, 193, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
6, d4g03B1, 0.9938, 0.41, 1.000, 192, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
7, d4g04B1, 0.9933, 0.43, 1.000, 192, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
8, d3lu7A1, 0.9932, 0.43, 1.000, 192, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
9, d4lb2A1, 0.9928, 0.44, 1.000, 192, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
10, d4g03A1, 0.9926, 0.45, 1.000, 192, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
11, d4g04A1, 0.9925, 0.45, 1.000, 192, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
12, d4la0A1, 0.9922, 0.46, 1.000, 195, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
13, d2bxgA3, 0.9922, 0.46, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
14, d4emxB1, 0.9919, 0.47, 1.000, 193, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
15, d2bxfA3, 0.9919, 0.47, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
16, d4emxA1, 0.9918, 0.47, 1.000, 195, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
17, d2bx8A3, 0.9918, 0.47, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
18, d2bxfB3, 0.9917, 0.48, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
19, d3lu8A1, 0.9915, 0.49, 1.000, 192, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
20, d2bx8B3, 0.9913, 0.50, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
21, d4l9qA1, 0.9911, 0.49, 1.000, 195, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
22, d3lu6B1, 0.9911, 0.50, 1.000, 192, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
23, d2bxgB3, 0.9911, 0.50, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
24, d2bxcB3, 0.9911, 0.50, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
25, d1e7bB1, 0.9909, 0.50, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
26, d1e7aB1, 0.9909, 0.51, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
27, d3lu6A1, 0.9907, 0.51, 1.000, 192, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
28, d2bxhB1, 0.9906, 0.51, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
29, d2bxdB3, 0.9906, 0.52, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
30, d1e78B1, 0.9904, 0.52, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
31, d4la0B1, 0.9901, 0.52, 1.000, 194, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
32, d4l9qB1, 0.9900, 0.53, 1.000, 192, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
33, d2bxhA1, 0.9898, 0.53, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
34, d2bxdA3, 0.9898, 0.53, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
35, d1e7aA1, 0.9898, 0.53, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
36, d1e7bA1, 0.9894, 0.55, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
37, d2bxcA3, 0.9891, 0.55, 1.000, 192, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
38, d1e78A1, 0.9890, 0.55, 1.000, 192, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
39, d4lb2B1, 0.9885, 0.56, 1.000, 192, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
40, d4l9kA1, 0.9881, 0.57, 1.000, 192, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
41, d5ujbB1, 0.9874, 0.59, 1.000, 193, 192, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
42, d4k71A1, 0.9871, 0.60, 1.000, 194, 192, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
43, p5fuoA1, 0.9863, 0.61, 1.000, 193, 192, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
44, d5ujbA1, 0.9840, 0.69, 1.000, 193, 192, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
45, d4l9kB1, 0.9838, 0.68, 1.000, 192, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
46, d5x52A1, 0.9828, 0.79, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
47, p4k2cA1, 0.9813, 0.72, 1.000, 194, 192, HSA LIGAND FREE
48, p5yoqA1, 0.9744, 0.96, 1.000, 195, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
49, d5x52B1, 0.9698, 0.86, 1.000, 192, 190, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
50, d3v09A1, 0.9691, 1.10, 0.667, 196, 192, CRYSTAL STRUCTURE OF RABBIT SERUM ALBUMIN
51, d5id9A1, 0.9669, 0.92, 0.754, 192, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
52, d4n0fJ1, 0.9662, 1.09, 1.000, 194, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
53, d4n0fG1, 0.9660, 1.10, 1.000, 194, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
54, d4n0fD1, 0.9655, 1.10, 1.000, 194, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
55, d4n0fM1, 0.9651, 1.11, 1.000, 194, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
56, d6ezqA1, 0.9649, 0.64, 1.000, 190, 188, HUMAN SERUM ALBUMIN COMPLEXED WITH NBD-C12 FATTY ACID
57, d4k71D1, 0.9641, 1.03, 1.000, 195, 192, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
58, d5otbD1, 0.9629, 1.03, 0.712, 193, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
59, d4or0A1, 0.9625, 1.07, 0.707, 194, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
60, d4f5vA1, 0.9625, 1.07, 0.644, 196, 191, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN
61, d3lu8B1, 0.9621, 0.62, 1.000, 187, 187, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
62, d4or0B1, 0.9616, 1.08, 0.707, 194, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
63, p5yoqB1, 0.9612, 0.74, 0.984, 191, 188, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
64, d2bxiA3, 0.9612, 1.13, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
65, d4ot2A1, 0.9609, 1.12, 0.754, 192, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
66, d5otbB1, 0.9607, 1.06, 0.712, 193, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
67, d4zbrA1, 0.9607, 1.13, 0.754, 192, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN
68, d4f5sA1, 0.9607, 1.09, 0.707, 195, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
69, d5dqfA1, 0.9605, 1.11, 0.754, 192, 191, HORSE SERUM ALBUMIN (ESA) IN COMPLEX WITH CETIRIZINE
70, d2bxmA3, 0.9603, 1.13, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
71, d4f5tA1, 0.9600, 1.11, 0.754, 195, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
72, d3jryB1, 0.9598, 1.58, 1.000, 192, 192, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
73, d5otbA1, 0.9597, 1.08, 0.712, 193, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
74, d5dbyA1, 0.9597, 1.15, 0.754, 192, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN OBTAINED IN DISPLACEMENT EXPERIMENT
75, d2bxkA3, 0.9597, 1.14, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AZAPROPAZONE AND INDOMETHACIN
76, d5ijeA1, 0.9595, 1.13, 0.754, 193, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 30 MM ZINC AT PH 7.4
77, d4zbqA1, 0.9594, 1.15, 0.754, 192, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC
78, d4hgkA1, 0.9594, 0.78, 1.000, 189, 188, SHARK IGNAR VARIABLE DOMAIN
79, d3jryA1, 0.9593, 1.59, 1.000, 192, 192, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
80, d4lb9A1, 0.9590, 1.15, 1.000, 195, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE
81, d5otbC1, 0.9589, 1.11, 0.712, 193, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
82, d4l8uA1, 0.9587, 1.16, 1.000, 195, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN
83, p3jqzA1, 0.9582, 1.21, 1.000, 197, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
84, d4po0A1, 0.9572, 1.21, 1.000, 197, 192, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
85, d5iiuA1, 0.9568, 1.16, 0.654, 195, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 10 MM ZINC AT PH 6.9
86, d5orfC1, 0.9567, 1.17, 0.754, 193, 191, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
87, d4f5sB1, 0.9567, 1.11, 0.717, 195, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
88, d5iihA1, 0.9566, 1.15, 0.707, 195, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 2.5 MM ZINC AT PH 7.4
89, d3v03A1, 0.9560, 1.18, 0.754, 192, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
90, d4jk4B1, 0.9559, 1.15, 0.707, 193, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
91, d3v03B1, 0.9559, 1.16, 0.707, 194, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
92, d5v0vA1, 0.9554, 1.15, 0.707, 193, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN COMPLEX WITH ETODOLAC
93, d5oswA1, 0.9551, 1.18, 0.754, 193, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN COMPLEX WITH 35-DIIODOSALICYLIC ACID
94, d2bxnA3, 0.9548, 1.17, 0.712, 195, 191, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
95, d2bxqA3, 0.9545, 1.20, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE PHENYLBUTAZONE AND INDOMETHACIN
96, d2i2zA3, 0.9541, 1.21, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN
97, d1ha2A1, 0.9541, 1.22, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S- (-) ENANTIOMER OF WARFARIN
98, d4z69A1, 0.9540, 1.21, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
99, d1e7eA1, 0.9539, 1.22, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)
100, d2xsiA1, 0.9537, 1.21, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-GLUTAMATE AND MYRISTIC ACID
101, d5orfB1, 0.9536, 1.22, 1.000, 194, 192, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
102, d2xvwA1, 0.9536, 1.19, 0.717, 195, 191, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ARGININE AND MYRISTIC ACID
103, d1h9zA1, 0.9535, 1.22, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
104, d4z69I1, 0.9532, 1.23, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
105, d2i30A3, 0.9531, 1.22, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID
106, d4jk4A1, 0.9526, 1.22, 1.000, 194, 192, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
107, d2bxoA3, 0.9526, 1.19, 0.707, 194, 191, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
108, d4bkeA1, 0.9522, 1.23, 1.000, 194, 192, RECOMBINANT HUMAN SERUM ALBUMIN WITH PALMITIC ACID. SYNTHETIC CATIONIC ANTIMICROBIAL PEPTIDES BIND WITH THEIR HYDROPHOBIC PARTS TO DRUG SITE II OF HUMAN SERUM ALBUMIN
109, d1gnjA1, 0.9521, 1.23, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-581114-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
110, d2xvvA1, 0.9520, 1.24, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE AND MYRISTIC ACID
111, d2bxpA3, 0.9513, 1.24, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
112, d1hk4A1, 0.9511, 1.25, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
113, d4lufA1, 0.9510, 1.25, 1.000, 194, 192, CRYSTAL STRUCTURE OF OVINE SERUM ALBUMIN
114, d5orfD1, 0.9509, 1.23, 0.717, 195, 191, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
115, d1e7fA1, 0.9508, 1.24, 0.717, 195, 191, HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)
116, d5oriA1, 0.9502, 1.26, 1.000, 194, 192, STRUCTURE OF CAPRINE SERUM ALBUMIN IN ORTHORHOMBIC CRYSTAL SYSTEM
117, d3cx9A1, 0.9498, 1.20, 0.712, 195, 191, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND LYSOPHOSPHATIDYLETHANOLAMINE
118, d4luhA1, 0.9495, 1.27, 1.000, 194, 192, COMPLEX OF OVINE SERUM ALBUMIN WITH 35-DIIODOSALICYLIC ACID
119, d5gixB1, 0.9492, 1.24, 0.717, 195, 191, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
120, d3sqjA1, 0.9492, 1.28, 1.000, 194, 192, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
121, d1e7iA1, 0.9492, 1.27, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)
122, d1e7hA1, 0.9492, 1.28, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)
123, d1n5uA1, 0.9491, 1.28, 1.000, 194, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
124, d3sqjB1, 0.9490, 1.28, 1.000, 195, 192, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
125, d5ij5A1, 0.9488, 1.27, 1.000, 194, 192, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 50 MM ZINC AT PH 4.5
126, d3a73B1, 0.9487, 1.27, 0.754, 193, 191, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
127, d3b9mA3, 0.9485, 1.28, 1.000, 195, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE 3 -AZIDO-3 - DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID
128, d2bxlA3, 0.9484, 1.29, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 35- DIIODOSALICYLIC ACID
129, d1e7gA1, 0.9481, 1.29, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID)
130, p5yxeA1, 0.9479, 1.29, 1.000, 194, 192, CRYSTAL STRUCTURE ANALYSIS OF FELINE SERUM ALBUMIN
131, d5giyA1, 0.9479, 0.79, 0.774, 187, 186, HSA-PALMITIC ACID-[RUCL5(IND)]2-
132, d5gixA1, 0.9478, 1.30, 1.000, 194, 192, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
133, d3tdlA1, 0.9478, 1.30, 1.000, 194, 192, STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA
134, d1e7cA1, 0.9478, 1.30, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
135, d1bkeA1, 0.9477, 1.29, 1.000, 194, 192, HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- IODOBENZOIC ACID
136, d5id7B1, 0.9476, 1.29, 1.000, 193, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
137, d1gniA1, 0.9473, 1.30, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID)
138, d1bj5A1, 0.9473, 1.30, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
139, d2bxaA3, 0.9472, 1.30, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
140, d2xw0A1, 0.9469, 0.41, 1.000, 183, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
141, d2xvqA1, 0.9469, 0.42, 1.000, 183, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
142, d2bxeA3, 0.9469, 0.42, 1.000, 183, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
143, d5ijfA1, 0.9468, 0.42, 1.000, 183, 183, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN THE PRESENCE OF 0.5 MM ZINC AT PH 9.0
144, d5id7A1, 0.9465, 0.58, 1.000, 186, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
145, d2xw1A1, 0.9464, 1.32, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
146, d5orfA1, 0.9462, 0.44, 1.000, 183, 183, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
147, d3b9lA3, 0.9462, 1.19, 0.684, 195, 190, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT
148, d3v08A1, 0.9460, 1.31, 1.000, 194, 192, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
149, d2ydfA1, 0.9459, 1.33, 0.754, 193, 191, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
150, d4hgmB1, 0.9454, 0.46, 1.000, 183, 183, SHARK IGNAR VARIABLE DOMAIN
151, d1hk5A1, 0.9450, 0.77, 0.978, 186, 185, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
152, p5vnwA1, 0.9449, 1.33, 1.000, 194, 192, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
153, d3uivA1, 0.9449, 1.15, 1.000, 192, 189, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
154, d2vufB1, 0.9447, 1.33, 1.000, 194, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
155, d4hgkB1, 0.9445, 0.49, 1.000, 183, 183, SHARK IGNAR VARIABLE DOMAIN
156, d2xvuA1, 0.9445, 0.63, 1.000, 185, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
157, d5iixA1, 0.9440, 0.50, 1.000, 183, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 15 MM ZINC AT PH 6.5
158, d3uivH1, 0.9424, 1.08, 0.754, 189, 187, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
159, d3a73A1, 0.9423, 1.35, 1.000, 194, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
160, d2vueA3, 0.9414, 1.36, 1.000, 195, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
161, d1o9xA1, 0.9409, 0.43, 1.000, 182, 182, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
162, d2xvuB1, 0.9404, 1.37, 1.000, 193, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
163, d2vufA1, 0.9401, 0.46, 1.000, 182, 182, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
164, p5vnwB1, 0.9383, 0.47, 1.000, 182, 182, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
165, p5ifoA1, 0.9359, 1.23, 1.000, 190, 189, X-RAY STRUCTURE OF HSA-MYR-KP1019
166, p3jqzB1, 0.9322, 1.26, 1.000, 191, 189, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
167, d1hk1A1, 0.9314, 1.33, 1.000, 193, 189, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
168, d1hk3A1, 0.9313, 0.42, 1.000, 180, 180, HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
169, d1hk2A1, 0.9310, 0.42, 1.000, 180, 180, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
170, d4s1yA1, 0.9307, 0.43, 1.000, 180, 180, X-RAY STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH CISPLATIN
171, d2ydfB1, 0.9304, 0.44, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
172, d2bxaB3, 0.9299, 0.46, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
173, d2xw1B1, 0.9298, 0.48, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
174, d2xvqB1, 0.9298, 0.48, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
175, d2xw0B1, 0.9297, 0.48, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
176, d2bxeB3, 0.9296, 0.48, 1.000, 180, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
177, d4f5uA1, 0.9269, 0.49, 1.000, 180, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN AT 2.04 RESOLUTION
178, p4iw1A1, 0.9259, 1.53, 0.754, 195, 191, HSA-FRUCTOSE COMPLEX
179, d2vueB3, 0.9259, 0.58, 1.000, 181, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
180, d4j2vA1, 0.9258, 0.60, 1.000, 180, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
181, d2vdbA3, 0.9243, 1.55, 0.754, 193, 191, STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE
182, d1tf0A1, 0.9165, 1.19, 0.984, 186, 186, CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN
183, d5hozA1, 0.9148, 0.80, 1.000, 180, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN (ESA) AT PH 9.0
184, d1uorA1, 0.9118, 1.12, 0.747, 184, 182, X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
185, d4e99A1, 0.9002, 1.65, 0.810, 193, 189, HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM
186, p5ghkA1, 0.8902, 0.99, 1.000, 179, 179, CRYSTAL STRUCTURE ANALYSIS OF CANINE SERUM ALBUMIN
187, p5oklA2, 0.7570, 0.92, 0.744, 179, 176, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
188, p5oklB2, 0.7535, 2.12, 0.327, 164, 162, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
189, d5id7A2, 0.7504, 2.12, 0.327, 164, 162, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
190, d3b9lA1, 0.7493, 1.87, 0.308, 161, 159, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT
191, d3b9mA1, 0.7488, 3.43, 0.239, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE 3 -AZIDO-3 - DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID
192, d5otbC2, 0.7485, 3.43, 0.239, 192, 184, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
193, d3uivA2, 0.7483, 3.44, 0.239, 192, 184, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
194, d3uivH2, 0.7482, 3.59, 0.232, 192, 185, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
195, d2xw0B2, 0.7478, 3.43, 0.239, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
196, d2bxiA1, 0.7478, 3.44, 0.239, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
197, d5id7B2, 0.7477, 3.50, 0.245, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
198, d1gniA2, 0.7475, 3.38, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID)
199, d1e7cA2, 0.7474, 3.45, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
200, d5iihA2, 0.7473, 3.41, 0.240, 192, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 2.5 MM ZINC AT PH 7.4
201, d2i30A1, 0.7473, 3.41, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID
202, d2bxqA1, 0.7473, 3.46, 0.266, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE PHENYLBUTAZONE AND INDOMETHACIN
203, d6ezqA2, 0.7471, 3.38, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH NBD-C12 FATTY ACID
204, d4g03B2, 0.7471, 3.40, 0.240, 192, 183, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
205, d2xw1B2, 0.7471, 3.47, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
206, d1gnjA2, 0.7471, 3.47, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-581114-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
207, d5hozA2, 0.7470, 3.49, 0.245, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN (ESA) AT PH 9.0
208, d2bxkA1, 0.7469, 3.41, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AZAPROPAZONE AND INDOMETHACIN
209, d5otbD2, 0.7467, 3.41, 0.251, 192, 183, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
210, d5otbB2, 0.7467, 3.39, 0.240, 192, 183, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
211, d2bxmA1, 0.7467, 3.41, 0.235, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
212, d5oswA2, 0.7466, 3.52, 0.228, 192, 184, STRUCTURE OF CAPRINE SERUM ALBUMIN IN COMPLEX WITH 35-DIIODOSALICYLIC ACID
213, d4s1yA2, 0.7466, 3.39, 0.240, 192, 183, X-RAY STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH CISPLATIN
214, d2bxpA1, 0.7465, 3.52, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
215, d2bxfA1, 0.7463, 3.48, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
216, d1e7fA2, 0.7463, 3.38, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)
217, d5orfC2, 0.7462, 3.51, 0.245, 192, 184, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
218, d5dqfA2, 0.7461, 3.49, 0.239, 192, 184, HORSE SERUM ALBUMIN (ESA) IN COMPLEX WITH CETIRIZINE
219, d5v0vA2, 0.7460, 3.40, 0.232, 192, 181, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN COMPLEX WITH ETODOLAC
220, d4l9qA2, 0.7460, 3.46, 0.266, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
221, d3jryA2, 0.7460, 3.35, 0.268, 192, 183, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
222, d3v09A2, 0.7459, 3.61, 0.238, 192, 185, CRYSTAL STRUCTURE OF RABBIT SERUM ALBUMIN
223, d3a73A2, 0.7459, 3.47, 0.246, 192, 183, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
224, d2xvwA2, 0.7459, 3.53, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ARGININE AND MYRISTIC ACID
225, d1e7eA2, 0.7458, 3.48, 0.239, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)
226, d5iiuA2, 0.7457, 3.52, 0.234, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 10 MM ZINC AT PH 6.9
227, d4zbqA2, 0.7457, 3.41, 0.240, 192, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC
228, d3a73B2, 0.7457, 3.47, 0.266, 192, 184, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
229, d2bxfB1, 0.7457, 3.48, 0.250, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
230, d2xw0A2, 0.7456, 3.47, 0.239, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
231, d2vufB2, 0.7456, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
232, d2bxnA1, 0.7456, 3.52, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
233, d2bxcB1, 0.7455, 3.50, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
234, d4zbrA2, 0.7454, 3.41, 0.240, 192, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN
235, d3lu8A2, 0.7454, 3.49, 0.245, 192, 184, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
236, d2xvqB2, 0.7454, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
237, d1e7aA2, 0.7454, 3.60, 0.227, 192, 185, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
238, d4g04B2, 0.7453, 3.53, 0.245, 192, 184, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
239, d2bxdB1, 0.7453, 3.60, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
240, d1hk5A2, 0.7453, 3.50, 0.245, 192, 184, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
241, d2bxoA1, 0.7452, 3.49, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
242, d2bx8B1, 0.7452, 3.42, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
243, d1hk2A2, 0.7451, 3.42, 0.240, 192, 183, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
244, d1e78B2, 0.7451, 3.50, 0.245, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
245, d4lb9A2, 0.7450, 3.61, 0.238, 192, 185, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE
246, d3jryB2, 0.7450, 3.49, 0.245, 192, 184, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
247, d4emxA2, 0.7449, 3.48, 0.239, 192, 184, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
248, d2ydfB2, 0.7449, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
249, d2xw1A2, 0.7448, 3.60, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
250, d2bxlA1, 0.7448, 3.52, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 35- DIIODOSALICYLIC ACID
251, d1e7aB2, 0.7448, 3.53, 0.234, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
252, d3v08A2, 0.7447, 3.38, 0.240, 192, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
253, d2xvuB2, 0.7447, 3.50, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
254, d1bkeA2, 0.7447, 3.50, 0.245, 192, 184, HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- IODOBENZOIC ACID
255, d4ot2A2, 0.7446, 3.51, 0.245, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
256, d2ydfA2, 0.7446, 3.41, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
257, d2vufA2, 0.7446, 3.52, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
258, d2bxhB2, 0.7446, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
259, d2bxhA2, 0.7446, 3.62, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
260, d2bxdA1, 0.7446, 3.50, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
261, d2bxaB1, 0.7445, 3.54, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
262, d1hk4A2, 0.7445, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
263, d1h9zA2, 0.7445, 3.52, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
264, d1bj5A2, 0.7445, 3.41, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
265, d5otbA2, 0.7444, 3.43, 0.240, 192, 183, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
266, d4la0A2, 0.7444, 3.44, 0.240, 192, 183, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
267, d2bxcA1, 0.7444, 3.47, 0.235, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
268, d1e7gA2, 0.7444, 3.61, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID)
269, d1e7bB2, 0.7444, 3.52, 0.245, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
270, d1e7iA2, 0.7443, 3.45, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)
271, d4g03A2, 0.7442, 3.51, 0.245, 192, 184, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
272, d2xsiA2, 0.7442, 3.46, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-GLUTAMATE AND MYRISTIC ACID
273, d1e78A2, 0.7442, 3.51, 0.245, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
274, d4f5vA2, 0.7441, 3.54, 0.234, 192, 184, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN
275, d4bkeA2, 0.7441, 3.53, 0.245, 192, 184, RECOMBINANT HUMAN SERUM ALBUMIN WITH PALMITIC ACID. SYNTHETIC CATIONIC ANTIMICROBIAL PEPTIDES BIND WITH THEIR HYDROPHOBIC PARTS TO DRUG SITE II OF HUMAN SERUM ALBUMIN
276, d3v03B2, 0.7441, 3.65, 0.238, 192, 185, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
277, d4emxB2, 0.7440, 3.45, 0.240, 192, 183, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
278, d1ha2A2, 0.7440, 3.30, 0.246, 192, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S- (-) ENANTIOMER OF WARFARIN
279, d1ao6B2, 0.7440, 3.61, 0.238, 192, 185, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
280, d2xvvA2, 0.7439, 3.42, 0.230, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE AND MYRISTIC ACID
281, d2bx8A1, 0.7439, 3.61, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
282, d1hk1A2, 0.7439, 3.56, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
283, d4po0A2, 0.7437, 3.64, 0.238, 192, 185, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
284, d2i2zA1, 0.7437, 3.51, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN
285, d1bm0B2, 0.7437, 3.43, 0.246, 192, 183, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
286, d5orfB2, 0.7436, 3.37, 0.242, 191, 182, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
287, d2xvqA2, 0.7436, 3.61, 0.227, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
288, d4z69I2, 0.7435, 3.51, 0.228, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
289, d1hk3A2, 0.7435, 3.56, 0.234, 192, 184, HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
290, d1bm0A2, 0.7435, 3.48, 0.239, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
291, d4z69A2, 0.7434, 3.53, 0.245, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
292, d3v03A2, 0.7434, 3.61, 0.238, 192, 185, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
293, d5ijfA2, 0.7433, 3.48, 0.239, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN THE PRESENCE OF 0.5 MM ZINC AT PH 9.0
294, d5iixA2, 0.7433, 3.39, 0.244, 192, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 15 MM ZINC AT PH 6.5
295, d5dbyA2, 0.7433, 3.62, 0.238, 192, 185, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN OBTAINED IN DISPLACEMENT EXPERIMENT
296, d4lb2B2, 0.7433, 3.49, 0.266, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
297, d2vueB1, 0.7433, 3.52, 0.272, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
298, d1e7hA2, 0.7433, 3.61, 0.227, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)
299, d5orfA2, 0.7432, 3.53, 0.245, 192, 184, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
300, d2bxaA1, 0.7432, 3.45, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
301, d1ao6A2, 0.7431, 3.48, 0.230, 192, 183, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
302, d4l9kA2, 0.7430, 3.55, 0.234, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
303, d3sqjB2, 0.7430, 3.62, 0.238, 192, 185, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
304, d3lu7A2, 0.7430, 3.62, 0.238, 192, 185, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
305, d2xvuA2, 0.7430, 3.64, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
306, d2vdbA1, 0.7430, 3.49, 0.239, 192, 184, STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE
307, d1e7bA2, 0.7430, 3.52, 0.245, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
308, d5ij5A2, 0.7429, 3.67, 0.227, 192, 185, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 50 MM ZINC AT PH 4.5
309, d4lb2A2, 0.7428, 3.39, 0.230, 192, 183, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
310, d4g04A2, 0.7428, 3.62, 0.238, 192, 185, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
311, d5ijeA2, 0.7427, 3.54, 0.250, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 30 MM ZINC AT PH 7.4
312, d5giyA2, 0.7427, 3.62, 0.227, 192, 185, HSA-PALMITIC ACID-[RUCL5(IND)]2-
313, d3lu8B2, 0.7426, 3.63, 0.238, 192, 185, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
314, d2bxgB1, 0.7426, 3.44, 0.251, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
315, d3sqjA2, 0.7425, 3.62, 0.232, 192, 185, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
316, d2vueA1, 0.7423, 3.54, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
317, d5oriA2, 0.7422, 3.56, 0.234, 192, 184, STRUCTURE OF CAPRINE SERUM ALBUMIN IN ORTHORHOMBIC CRYSTAL SYSTEM
318, d1n5uA2, 0.7422, 3.49, 0.239, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
319, d5x52B2, 0.7421, 3.66, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
320, d2bxgA1, 0.7421, 3.59, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
321, d4f5tA2, 0.7420, 3.48, 0.239, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
322, d5x52A2, 0.7419, 3.64, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
323, d4la0B2, 0.7419, 3.58, 0.234, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
324, d5orfD2, 0.7418, 3.42, 0.251, 192, 183, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
325, d4l8uA2, 0.7418, 3.65, 0.238, 192, 185, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN
326, d5id9A2, 0.7417, 3.52, 0.245, 192, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
327, d3cx9A2, 0.7416, 3.54, 0.228, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND LYSOPHOSPHATIDYLETHANOLAMINE
328, d5ujbB2, 0.7415, 3.48, 0.239, 192, 184, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
329, d4f5sA2, 0.7415, 3.66, 0.254, 192, 185, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
330, d5gixB2, 0.7414, 3.43, 0.240, 192, 183, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
331, d4jk4A2, 0.7413, 3.51, 0.240, 192, 183, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
332, d5gixA2, 0.7412, 3.44, 0.244, 192, 180, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
333, d4jk4B2, 0.7409, 3.54, 0.234, 192, 184, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
334, d2bxeB1, 0.7409, 3.47, 0.240, 192, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
335, d1o9xA2, 0.7409, 3.55, 0.234, 192, 184, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
336, d4hgkA2, 0.7408, 3.59, 0.245, 192, 184, SHARK IGNAR VARIABLE DOMAIN
337, d3tdlA2, 0.7405, 3.60, 0.245, 192, 184, STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA
338, d4hgmB2, 0.7404, 3.46, 0.240, 192, 183, SHARK IGNAR VARIABLE DOMAIN
339, d5ujbA2, 0.7403, 3.53, 0.245, 192, 184, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
340, d4lufA2, 0.7401, 3.62, 0.222, 192, 185, CRYSTAL STRUCTURE OF OVINE SERUM ALBUMIN
341, d4l9kB2, 0.7401, 3.52, 0.245, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
342, d1tf0A2, 0.7400, 3.59, 0.234, 192, 184, CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN
343, d3lu7B2, 0.7393, 3.46, 0.235, 192, 183, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
344, d4luhA2, 0.7390, 3.67, 0.227, 192, 185, COMPLEX OF OVINE SERUM ALBUMIN WITH 35-DIIODOSALICYLIC ACID
345, d4hgkB2, 0.7390, 3.55, 0.234, 192, 184, SHARK IGNAR VARIABLE DOMAIN
346, d3lu6B2, 0.7386, 3.58, 0.245, 192, 184, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
347, d4f5sB2, 0.7383, 3.47, 0.235, 192, 183, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
348, d3lu6A2, 0.7381, 3.65, 0.238, 192, 185, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
349, d4or0A2, 0.7378, 3.62, 0.245, 192, 184, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
350, d2bxeA1, 0.7378, 3.42, 0.246, 192, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
351, d4n0fG2, 0.7371, 3.64, 0.234, 192, 184, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
352, d4n0fD2, 0.7361, 3.33, 0.247, 192, 178, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
353, d4n0fJ2, 0.7360, 3.65, 0.234, 192, 184, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
354, d4l9qB2, 0.7360, 3.69, 0.234, 192, 184, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
355, d4n0fM2, 0.7357, 3.70, 0.234, 192, 184, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
356, d4or0B2, 0.7354, 3.70, 0.234, 192, 184, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
357, d4k71A2, 0.7354, 3.71, 0.227, 192, 185, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
358, p5oklA1, 0.7344, 3.71, 0.234, 192, 184, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
359, p5fuoA2, 0.7343, 3.51, 0.244, 192, 180, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
360, p5yoqA4, 0.7335, 3.80, 0.238, 192, 185, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
361, p5ifoA2, 0.7334, 3.17, 0.193, 195, 176, X-RAY STRUCTURE OF HSA-MYR-KP1019
362, d4k71D2, 0.7332, 3.17, 0.193, 195, 176, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
363, p5oklB1, 0.7327, 3.26, 0.254, 184, 177, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
364, p5vnwB2, 0.7324, 3.17, 0.250, 184, 176, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
365, d4e99A2, 0.7324, 3.32, 0.247, 188, 178, HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM
366, p4iw1A2, 0.7319, 3.77, 0.245, 192, 184, HSA-FRUCTOSE COMPLEX
367, p5yoqB2, 0.7316, 3.26, 0.192, 195, 177, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
368, p4iw2A4, 0.7315, 3.31, 0.247, 188, 178, HSA-GLUCOSE COMPLEX
369, p4n0uD4, 0.7307, 3.67, 0.227, 192, 185, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
370, d4f5uA2, 0.7307, 3.23, 0.239, 184, 176, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN AT 2.04 RESOLUTION
371, d4j2vA2, 0.7299, 3.28, 0.254, 184, 177, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
372, d1kw2A1, 0.7289, 3.26, 0.254, 184, 177, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
373, p4k2cB4, 0.7265, 3.30, 0.243, 184, 177, HSA LIGAND FREE
374, d1uorA2, 0.7263, 3.55, 0.250, 192, 184, X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
375, p3jqzA2, 0.7252, 3.55, 0.250, 192, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
376, d1kw2B1, 0.7245, 3.44, 0.208, 195, 183, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
377, d4k71A3, 0.7211, 3.44, 0.208, 195, 183, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
378, d4n0fD3, 0.7209, 3.32, 0.243, 184, 177, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
379, d4n0fG3, 0.7205, 3.70, 0.238, 192, 185, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
380, d4n0fM3, 0.7193, 3.24, 0.250, 184, 176, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
381, d4n0fJ3, 0.7193, 3.50, 0.198, 193, 182, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
382, d4f5tA3, 0.7193, 3.51, 0.154, 197, 182, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
383, d5dqfA3, 0.7190, 3.67, 0.147, 197, 184, HORSE SERUM ALBUMIN (ESA) IN COMPLEX WITH CETIRIZINE
384, d1j7eB1, 0.7186, 3.68, 0.147, 197, 184, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
385, d1j78B1, 0.7184, 3.69, 0.147, 197, 184, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
386, d5ij5A3, 0.7159, 3.69, 0.147, 197, 184, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 50 MM ZINC AT PH 4.5
387, d5id9A3, 0.7154, 3.60, 0.142, 196, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
388, d4zbqA3, 0.7151, 3.33, 0.140, 196, 179, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC
389, d5iixA3, 0.7150, 3.40, 0.201, 189, 179, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 15 MM ZINC AT PH 6.5
390, d5iiuA3, 0.7145, 3.53, 0.200, 189, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 10 MM ZINC AT PH 6.9
391, d5dbyA3, 0.7140, 3.67, 0.158, 196, 183, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN OBTAINED IN DISPLACEMENT EXPERIMENT
392, d5v0vA3, 0.7130, 3.44, 0.133, 196, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN COMPLEX WITH ETODOLAC
393, d5ijeA3, 0.7121, 3.59, 0.122, 196, 181, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 30 MM ZINC AT PH 7.4
394, d5iihA3, 0.7116, 3.46, 0.133, 196, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 2.5 MM ZINC AT PH 7.4
395, d4zbrA3, 0.7113, 3.44, 0.145, 196, 179, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN
396, d4k71D3, 0.7112, 3.43, 0.123, 196, 179, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
397, p5ghkA4, 0.7110, 3.55, 0.144, 196, 180, CRYSTAL STRUCTURE ANALYSIS OF CANINE SERUM ALBUMIN
398, d2xw0B3, 0.7100, 3.57, 0.139, 196, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
399, d3v08A3, 0.7097, 3.59, 0.127, 196, 181, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
400, d2xw1B3, 0.7091, 3.53, 0.139, 196, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
401, d2bxcB2, 0.7089, 3.66, 0.134, 192, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
402, d2ydfB3, 0.7087, 3.67, 0.148, 203, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
403, d4ot2A3, 0.7086, 3.65, 0.128, 194, 180, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
404, d5hozA3, 0.7083, 3.58, 0.133, 196, 181, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN (ESA) AT PH 9.0
405, p6ci6A5, 0.7080, 3.69, 0.133, 194, 181, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NABUMETONE
406, d2ydfA3, 0.7080, 3.64, 0.144, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
407, d2xvqB3, 0.7076, 3.57, 0.123, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
408, d5oriA3, 0.7072, 3.63, 0.153, 196, 183, STRUCTURE OF CAPRINE SERUM ALBUMIN IN ORTHORHOMBIC CRYSTAL SYSTEM
409, d2bxaB2, 0.7069, 3.68, 0.138, 196, 181, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
410, d1ma9A1, 0.7066, 3.62, 0.143, 203, 182, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN VITAMIN D BINDING PROTEIN AND RABBIT MUSCLE ACTIN
411, d2bxeA2, 0.7064, 3.59, 0.128, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
412, d2bxeB2, 0.7062, 3.54, 0.128, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
413, d4lufA3, 0.7061, 3.79, 0.137, 196, 183, CRYSTAL STRUCTURE OF OVINE SERUM ALBUMIN
414, d2bx8B2, 0.7059, 3.64, 0.122, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
415, d2xw1A3, 0.7058, 3.55, 0.194, 191, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
416, d2bxdB2, 0.7058, 3.58, 0.128, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
417, d5oswA3, 0.7053, 3.51, 0.136, 194, 177, STRUCTURE OF CAPRINE SERUM ALBUMIN IN COMPLEX WITH 35-DIIODOSALICYLIC ACID
418, d4luhA3, 0.7053, 3.69, 0.127, 196, 181, COMPLEX OF OVINE SERUM ALBUMIN WITH 35-DIIODOSALICYLIC ACID
419, d2xw0A3, 0.7050, 3.73, 0.117, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
420, d2bxgB2, 0.7049, 3.61, 0.123, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
421, d2bxaA2, 0.7048, 3.68, 0.128, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
422, d2xvqA3, 0.7042, 3.68, 0.139, 196, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
423, d1e7eA3, 0.7041, 3.58, 0.128, 196, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)
424, d1kxpD2, 0.7038, 3.66, 0.129, 194, 178, CRYSTAL STRUCTURE OF HUMAN VITAMIN D-BINDING PROTEIN IN COMPLEX WITH SKELETAL ACTIN
425, d1gniA3, 0.7033, 3.60, 0.152, 194, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID)
426, d4l9kA3, 0.7032, 3.59, 0.128, 194, 179, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
427, d4or0B3, 0.7031, 3.53, 0.136, 194, 177, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
428, d1gnjA3, 0.7023, 3.53, 0.123, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-581114-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
429, d2bxbB1, 0.7022, 3.45, 0.202, 190, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
430, d2bxbB2, 0.7020, 3.52, 0.124, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
431, d3b9lA2, 0.7018, 3.53, 0.148, 194, 176, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT
432, d4f5sA3, 0.7017, 3.64, 0.145, 196, 179, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
433, d2bxbA1, 0.7016, 3.56, 0.123, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
434, d3v03B3, 0.7014, 3.01, 0.273, 172, 165, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
435, d2bxdA2, 0.7007, 3.65, 0.156, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
436, d1e7iA3, 0.7007, 3.53, 0.134, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)
437, d4jk4B3, 0.7005, 3.74, 0.149, 196, 181, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
438, d2bxgA2, 0.7005, 3.02, 0.273, 172, 165, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
439, d4po0A3, 0.7000, 3.73, 0.134, 194, 179, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
440, d5otbA3, 0.6998, 3.70, 0.118, 194, 178, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
441, d2esgC1, 0.6998, 3.53, 0.118, 196, 178, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
442, d1hk5A3, 0.6996, 3.63, 0.124, 196, 178, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
443, d1ha2A3, 0.6995, 3.76, 0.149, 194, 181, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S- (-) ENANTIOMER OF WARFARIN
444, d4f5sB3, 0.6994, 3.80, 0.117, 196, 179, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
445, d3v03A3, 0.6994, 3.63, 0.122, 196, 180, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
446, d4l9kB3, 0.6992, 3.05, 0.273, 172, 165, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
447, d2bxmA2, 0.6992, 3.55, 0.129, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
448, d4jk4A3, 0.6991, 3.55, 0.135, 196, 178, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
449, d3b9mA2, 0.6989, 3.76, 0.155, 196, 181, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE 3 -AZIDO-3 - DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID
450, d1bkeA3, 0.6989, 3.73, 0.134, 196, 179, HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- IODOBENZOIC ACID
451, d2bxfB2, 0.6988, 3.56, 0.148, 194, 176, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
452, d4or0A3, 0.6985, 3.54, 0.135, 196, 178, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
453, d1h9zA3, 0.6985, 3.60, 0.145, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
454, d1e7fA3, 0.6985, 3.58, 0.128, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)
455, d1e7cA3, 0.6983, 3.56, 0.129, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
456, d4bkeA3, 0.6981, 3.69, 0.144, 194, 180, RECOMBINANT HUMAN SERUM ALBUMIN WITH PALMITIC ACID. SYNTHETIC CATIONIC ANTIMICROBIAL PEPTIDES BIND WITH THEIR HYDROPHOBIC PARTS TO DRUG SITE II OF HUMAN SERUM ALBUMIN
457, d5otbD3, 0.6980, 3.74, 0.155, 196, 181, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
458, d2bxcA2, 0.6979, 3.56, 0.135, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
459, d2bx8A2, 0.6978, 3.55, 0.135, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
460, d2bxnA2, 0.6975, 3.57, 0.134, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
461, d1bj5A3, 0.6973, 3.56, 0.129, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
462, d1n5uA3, 0.6972, 3.54, 0.128, 196, 179, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
463, d1e7hA3, 0.6972, 3.73, 0.139, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)
464, d3jryB3, 0.6970, 3.66, 0.150, 194, 180, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
465, d3jryA3, 0.6970, 3.59, 0.134, 196, 179, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
466, d1hk4A3, 0.6970, 3.58, 0.129, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
467, d4l9qB3, 0.6969, 3.58, 0.129, 196, 178, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
468, d2i2zA2, 0.6969, 3.57, 0.124, 195, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN
469, d2bxfA2, 0.6968, 3.35, 0.131, 191, 175, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
470, d4f5uA3, 0.6967, 3.35, 0.131, 191, 175, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN AT 2.04 RESOLUTION
471, d5orfB3, 0.6965, 3.58, 0.135, 196, 178, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
472, d4emxA3, 0.6964, 3.65, 0.157, 194, 178, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
473, d3a73A3, 0.6964, 3.58, 0.129, 196, 178, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
474, d2xvwA3, 0.6964, 3.72, 0.144, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ARGININE AND MYRISTIC ACID
475, d4z69I3, 0.6963, 3.76, 0.148, 196, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
476, d2bxqA2, 0.6961, 3.78, 0.139, 196, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE PHENYLBUTAZONE AND INDOMETHACIN
477, d2bxbA2, 0.6961, 3.77, 0.151, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
478, d3sqjB3, 0.6960, 3.42, 0.126, 189, 175, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
479, d4emxB3, 0.6959, 3.61, 0.134, 196, 179, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
480, d3lu8A3, 0.6959, 3.57, 0.124, 195, 178, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
481, d2xvvA3, 0.6959, 3.61, 0.134, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE AND MYRISTIC ACID
482, d2esgC2, 0.6959, 3.50, 0.131, 194, 175, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
483, d1ao6A3, 0.6959, 3.61, 0.129, 196, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
484, d1e7gA3, 0.6958, 3.77, 0.151, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID)
485, d1bm0A3, 0.6957, 3.76, 0.117, 194, 180, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
486, d4z69A3, 0.6956, 3.61, 0.134, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
487, d1e78B3, 0.6956, 3.76, 0.122, 194, 180, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
488, d3uivH3, 0.6955, 3.76, 0.122, 194, 180, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
489, d4l8uA3, 0.6954, 3.60, 0.129, 196, 178, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN
490, d2bxkA2, 0.6954, 3.78, 0.122, 194, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AZAPROPAZONE AND INDOMETHACIN
491, d4f5vA3, 0.6952, 3.58, 0.129, 195, 178, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN
492, d3cx9A3, 0.6952, 3.65, 0.128, 194, 179, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND LYSOPHOSPHATIDYLETHANOLAMINE
493, d5ijfA3, 0.6951, 3.58, 0.135, 196, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN THE PRESENCE OF 0.5 MM ZINC AT PH 9.0
494, d5orfA3, 0.6950, 3.60, 0.129, 196, 178, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
495, d2i30A2, 0.6950, 3.60, 0.140, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID
496, d2bxlA2, 0.6949, 3.93, 0.149, 196, 181, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 35- DIIODOSALICYLIC ACID
497, d5gixA3, 0.6947, 3.58, 0.135, 196, 178, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
498, d3uivA3, 0.6947, 3.77, 0.117, 194, 179, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
499, d5giyA3, 0.6945, 3.61, 0.140, 196, 178, HSA-PALMITIC ACID-[RUCL5(IND)]2-
500, d3lu8B3, 0.6945, 3.61, 0.128, 196, 179, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
501, d5orfD3, 0.6943, 3.57, 0.130, 195, 177, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
502, p3jqzB2, 0.6943, 3.60, 0.124, 195, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
503, d1e7aA3, 0.6943, 3.65, 0.129, 196, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
504, d1e7bA3, 0.6940, 3.60, 0.124, 195, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
505, d5otbC3, 0.6939, 3.62, 0.124, 194, 178, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
506, d5otbB3, 0.6937, 3.52, 0.147, 196, 177, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
507, d2bxiA2, 0.6937, 3.54, 0.136, 216, 176, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
508, d1bm0B3, 0.6937, 3.54, 0.136, 216, 176, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
509, d5gixB3, 0.6936, 3.60, 0.153, 194, 177, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
510, d4j2vA3, 0.6934, 3.73, 0.123, 194, 179, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
511, d1e7aB3, 0.6934, 3.77, 0.122, 196, 180, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
512, d4g03B3, 0.6931, 3.56, 0.135, 196, 178, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
513, d2bxpA2, 0.6929, 3.63, 0.134, 196, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
514, d1kw2A2, 0.6929, 3.78, 0.122, 194, 180, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
515, d2xsiA3, 0.6928, 3.62, 0.124, 195, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-GLUTAMATE AND MYRISTIC ACID
516, d1ao6B3, 0.6927, 3.80, 0.148, 196, 183, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
517, d3lu7B3, 0.6922, 3.81, 0.143, 194, 182, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
518, d1j78B2, 0.6920, 3.75, 0.157, 194, 178, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
519, d5orfC3, 0.6918, 3.60, 0.135, 195, 178, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
520, d3lu6B3, 0.6918, 3.68, 0.197, 190, 178, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
521, d3lu6A3, 0.6918, 3.68, 0.197, 190, 178, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
522, d4lb2A3, 0.6914, 3.60, 0.140, 196, 178, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
523, d4g04B3, 0.6912, 3.61, 0.136, 194, 177, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
524, d2bxoA2, 0.6911, 3.71, 0.152, 194, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
525, d3sqjA3, 0.6904, 3.64, 0.187, 188, 176, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
526, d1e78A3, 0.6904, 3.63, 0.135, 196, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
527, d3v09A3, 0.6903, 3.73, 0.130, 194, 177, CRYSTAL STRUCTURE OF RABBIT SERUM ALBUMIN
528, d4g04A3, 0.6899, 3.87, 0.145, 194, 179, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
529, d5id7A3, 0.6898, 3.76, 0.151, 194, 179, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
530, d1e7bB3, 0.6892, 3.72, 0.157, 194, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
531, d4lb9A3, 0.6889, 3.64, 0.128, 196, 179, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE
532, d4la0B3, 0.6888, 3.67, 0.124, 196, 178, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
533, d4g03A3, 0.6888, 3.72, 0.124, 194, 177, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
534, d3lu7A3, 0.6877, 3.82, 0.171, 195, 181, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
535, d5id7B3, 0.6870, 3.75, 0.157, 194, 178, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
536, d2vueA2, 0.6863, 3.60, 0.135, 196, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
537, d2vdbA2, 0.6855, 3.73, 0.140, 192, 178, STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE
538, p5fuoA3, 0.6854, 3.66, 0.129, 196, 178, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
539, d1j78A1, 0.6852, 3.72, 0.157, 194, 178, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
540, p3jqzB3, 0.6844, 3.84, 0.151, 194, 179, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
541, d3a73B3, 0.6844, 3.72, 0.157, 194, 178, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
542, d1lotA2, 0.6844, 3.62, 0.135, 196, 178, CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D-BINDING PROTEIN
543, d4lb2B3, 0.6843, 3.77, 0.146, 191, 178, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
544, d1j7eB2, 0.6842, 3.74, 0.151, 196, 179, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
545, d3tdlA3, 0.6827, 3.77, 0.117, 201, 179, STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA
546, d1uorA3, 0.6820, 3.46, 0.209, 174, 172, X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
547, d1o9xA3, 0.6811, 3.32, 0.247, 173, 166, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
548, d2vueB2, 0.6806, 3.53, 0.126, 189, 175, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
549, d2xvuA3, 0.6798, 3.56, 0.205, 188, 176, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
550, d1j7eA1, 0.6793, 3.83, 0.151, 194, 179, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
551, d1kw2B2, 0.6791, 3.72, 0.193, 188, 176, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
552, p5oklA3, 0.6767, 3.78, 0.123, 192, 179, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
553, p5oklB3, 0.6733, 3.92, 0.115, 195, 182, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
554, d1j78A2, 0.6728, 3.61, 0.131, 194, 176, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
555, d4la0A3, 0.6723, 3.65, 0.155, 187, 174, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
556, d4l9qA3, 0.6723, 3.64, 0.145, 185, 172, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
557, d1kxpD1, 0.6706, 3.34, 0.205, 176, 171, CRYSTAL STRUCTURE OF HUMAN VITAMIN D-BINDING PROTEIN IN COMPLEX WITH SKELETAL ACTIN
558, d6ezqA3, 0.6691, 3.66, 0.199, 190, 176, HUMAN SERUM ALBUMIN COMPLEXED WITH NBD-C12 FATTY ACID
559, d1j7eA2, 0.6677, 3.68, 0.147, 202, 177, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
560, d1hk2A3, 0.6671, 3.68, 0.147, 202, 177, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
561, d1ma9A2, 0.6635, 3.74, 0.147, 202, 177, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN VITAMIN D BINDING PROTEIN AND RABBIT MUSCLE ACTIN
562, d1hk3A3, 0.6634, 3.78, 0.198, 188, 177, HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
563, d2xvuB3, 0.6609, 4.08, 0.162, 194, 179, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
564, d1lotA1, 0.6603, 4.02, 0.157, 194, 178, CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D-BINDING PROTEIN
565, d2vufA3, 0.6577, 3.37, 0.204, 179, 167, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
566, d5x52A3, 0.6554, 3.25, 0.133, 181, 165, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
567, d1hk1A3, 0.6498, 3.92, 0.185, 188, 178, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
568, d5ujbA3, 0.6478, 3.79, 0.133, 188, 173, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
569, d1tf0A3, 0.6458, 3.57, 0.211, 179, 171, CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN
570, d5x52B3, 0.6425, 3.75, 0.139, 187, 173, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
571, d4e99A3, 0.6422, 3.58, 0.150, 183, 167, HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM
572, d2vufB3, 0.6408, 3.44, 0.217, 177, 166, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
573, d5ujbB3, 0.6397, 3.65, 0.143, 182, 168, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
574, d1ysxA1, 0.6382, 3.77, 0.130, 185, 169, SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMIN COMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL- XL AND BCL-2
575, d2bxhA3, 0.6350, 3.72, 0.148, 181, 169, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
576, d2bxhB3, 0.6305, 3.80, 0.131, 183, 168, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
577, d4s1yA3, 0.6145, 3.81, 0.130, 184, 169, X-RAY STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH CISPLATIN
578, p4n0uD1, 0.5274, 3.85, 0.126, 181, 167, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
579, p5ifoA4, 0.5225, 3.88, 0.149, 183, 168, X-RAY STRUCTURE OF HSA-MYR-KP1019
580, p4iw2A1, 0.5213, 3.43, 0.144, 174, 160, HSA-GLUCOSE COMPLEX
581, p4k2cB1, 0.5197, 3.73, 0.129, 180, 163, HSA LIGAND FREE
582, p6ci6A1, 0.5143, 4.05, 0.126, 196, 175, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NABUMETONE
